An Evaluation of the Characteristics of Patients with Gestational Choriocarcinoma in South-South, Nigeria

Authors

  • T. K. Nyengidiki Department of Obstetrics and Gynaecology, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, Nigeria Author
  • G. Bassey Department of Obstetrics and Gynaecology, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, Nigeria Author

DOI:

https://doi.org/10.60787/njgp.v13i2.150

Keywords:

Port Harcourt, gestational choriocarcinoma, Characteristics

Abstract

Background: Gestational trophoblastic diseases have been generally associated with the good outcome, especially in developed countries where early presentation and diagnosis is the norm.

Objective: This study seeks to determine the characteristics of patients with gestational choriocarcinoma at the University of Port Harcourt Teaching Hospital (UPTH), Nigeria.

Methods: This was a retrospective study of women who were treated for gestational choriocarcinoma at the UPTH over a 5-year period from January 1, 2008 to December 31, 2012.

Results: A total of 13 cases of gestational choriocarcinoma were treated in UPTH during the study period, and there were 16,720 deliveries giving a prevalence of 0.8/1000 deliveries. The majority of patients (76.9%) were of low socioeconomic class. 92.3% of patients presented with amenorrhea for 28 weeks. Histological examination of tissues extracted from previous miscarriages was not performed in 100% of patients. Eighty percent of all mortalities were associated with antecedent pregnancies being miscarriages. All patients managed were lost to follow-up within 32 weeks.

Conclusion: Gestational choriocarcinoma in Port Harcourt is associated with high mortality. Most patients with choriocarcinoma were of low socioeconomic class, presented late with lack of histological examination of previously extracted products of conception. Most of the patients were lost to follow-up within 32 weeks.

Downloads

Download data is not yet available.

References

Aghajanian P. Gestational trophoblastic diseases. In: DeCherney AH, Nathan L, Goodwin TM, Laufer N, editors. Current Obstetrics and Gynaecologic Diagnosis and Treatment. 10th ed. New York: McGraw-Hill; 2007. p. 885-6.

Mazur MT, Kurman RJ. Choriocarcinoma and placental site tumor. In: Szulman AE, Buchsbaum HJ, editor. Gestational Trophoblastic Disease.

New York: Springer-Verlag; 1985. p. 45.

Hertz R, Lewis J, Lipsett MB. Five years experience with chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in

women. Am J Obstet Gynaecol 1961;82:631.

Izhar R, Aziz-un-Nisa. Prognosis of gestational choriocarcinoma at Khyber Teaching Hospital Peshawar. J Ayub Med Coll Abbottabad

;15:45-8.

Mbamara NJ, Obiechina GU, Akabuike CJ, Umeononihu OS. Gestational trophoblastic disease in a tertiary Hospital in Nnewi, South

Eastern Nigeria. Niger Med J 2009;50:87-9.

Dim CC, Ezegwui HU. Choriocarcinoma in Enugu, South east Nigeria: A need for a shift from mortality to survival. Niger J Med 2013;22:252-6.

Olusanya O, Okpere E, Ezimokhai M. The importance of social class in voluntary fertility control. West Afr J Med 1985;4:205-12.

FIGO Committee on Gynecologic Oncology. Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic

neoplasia. Int J Gynaecol Obstet 2009;105:3-4.

Newland ES. Presentation and management of persistent gestational trophoblastic disease and gestational trophoblastic tumors in the UK.

In: Hancock BW, Newlands ES, Berkowitz RS, Cole LA, editors. Gestational Trophoblastic Disease. 3rd ed. London: International Society

for the Study of Trophoblastic Disease for the Study; 2003. p. 279-98. Available from: http://www.isstad.orgisstdbook: html. [Last accessed

on 2015 May 23].

Shah NT, Barroilhet L, Berkowitz RS, Goldstein DP, Horowitz N. A cost analysis of first‑line chemotherapy for low‑risk gestational trophoblastic

neoplasia. J Reprod Med 2012;57:211-8.

Byers TE, Wolf HJ, Bauer KR, Bolick-Aldrich S, Chen VW, Finch JL, et al. The impact of socioeconomic status on survival after cancer in the United States: Findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 2008;113:582-91.

Mourali M, Fkih C, Essoussi-ChikhaouiJ, Ben Haj HassineA, Binous N, Ben Zineb N, et al. Gestational trophoblastic disease in Tunisia. Tunis

Med 2008;86:665-9.

Thirumagal B, Sinha D, Raghavan R, Bhatti N. Gestational trophoblastic neoplasia: Are we compliant with the standards? J Obstet Gynaecol

;29:434-6.

Anuma ON, Umeora OU, Obuna JA, Agwu UM. Profiling gestational trophoblastic disease in a tertiary Hospital in South-East Nigeria. Trop J

Obstet Gynaecol 2009;26:151-64.

Osamor JO, Oluwasola AO, Adewole IF. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.

J Obstet Gynaecol 2002;22:423-5.

Roos LL, Magoon J, Gupta S, Chateau D, Veugelers PJ. Socioeconomic determinants of mortality in two Canadian provinces: Multilevel

modelling and neighborhood context. Soc Sci Med 2004;59:1435-47.

Gorey KM, Holowarty EJ, Fehringer G, Laukkanen E, Richter NL, Meyer CM. An international comparison of cancer survival; relatively

poor areas of Toronto, Ontario and three US metropolitan areas. J Public Health Med 2000;22(3):343-8

Downloads

Published

2015-01-01

Issue

Section

Original Articles

How to Cite

1.
Nyengidiki TK, Bassey G. An Evaluation of the Characteristics of Patients with Gestational Choriocarcinoma in South-South, Nigeria. NJGP [Internet]. 2015 Jan. 1 [cited 2025 Apr. 26];13(2):40-3. Available from: https://njgp.net.ng/index.php/home/article/view/150

Similar Articles

1-10 of 30

You may also start an advanced similarity search for this article.